Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Syndax Pharma Shares Rise on $35M Capital Raise, Credit Line and Positive Phase 1/2 Leukemia ...

Syndax Pharma Shares Rise on $35M Capital Raise, Credit Line and Positive Phase 1/2 Leukemia Trial Results Syndax Pharmaceuticals' shares traded 30% higher after the company reported it expects to raise $35 million from a common stock offering from five instituti...
Streetwise Reports | February 3, 2020 |

Supporting the Clean Energy Industry Through the COVID-19 Response

A Letter to the Clean Energy Industry Businesses and Employees Without doubt, Zinc8 Energy Solutions Inc. has the best possible partners to continue its path to full commercialization of its unique, patented, low-cost, long-duration energy storage system. On Apr...
Stephan Bogner | April 2, 2020 |

Revolutionizing Mental Health Treatment

(Click to play video.) Cybin Inc. ( NEO: CYBN , NYSE: CYBN , Forum ) is a Toronto-based life sciences company initially focused on psychedelic pharmaceutical therapies supporting research to advance psychedelic therapies centered on improving mental health and...
Featured Submission | August 13, 2021 |

Renewable Energy MLP Achieves 'Clean Results from Strong Hydrology' in Q2/19

The highlights of the quarterly update are presented in an iA Securities report. In a July 31 research note, iA Securities analyst Jeremy Rosenfield reported that Brookfield Renewable Energy Partners L.P.'s (BEP.UN:TSX; BEP:NYSE) Q2/19 results were "roughly...
Streetwise Reports | August 6, 2019 |

Mallinckrodt Shares Up 60% as It Announces Sale of Unit

Shares of Mallinckrodt Plc are trading more than 60% higher today on news that the company is selling its CDMO subsidiary BioVectra Inc. to H.I.G. Capital for $250 million. Global biopharmaceutical company Mallinckrodt Plc (MNK:NYSE) announced today that it has ent...
Streetwise Reports | September 11, 2019 |

SunPower's Energy Storage Reflecting Well on Its Shares

SunPower Corp. shares are trading 6% higher today as the firm announced that its Equinox Storage paired with its platform provides energy independence to residential users. Global sustainable energy company SunPower Corp. (SPWR:NASDAQ) today announced the introduc...
Streetwise Reports | September 20, 2019 |

Base Metals Miner Posts 'Strong Operating Performance' in Q3/19

The short-term outlook for the Canadian company is provided in a CIBC report. In an Oct. 25 research note, CIBC analyst Oscar Cabrera wrote that Lundin Mining Corp. (LUN:TSX) "continues to offer investors an attractive combination of a strong balance sheet,...
Streetwise Reports | November 7, 2019 |

Sales of Antibiotic Alternative for Livestock Feed Accelerate in Asia

With antibiotic resistance a major health issue, the search is on for effective alternatives to replace antibiotics in livestock feed to promote growth. A small-cap Canadian company, Avivagen Inc. (VIV:TSX.V) , has developed a feed supplement, OxC-beta™ Livestock, wh...
Streetwise Reports | November 18, 2019 |

InMed Shares Trade Up 25% After Becoming First to Advance Cannabinol into Clinical Trials

InMed Pharmaceuticals shares traded 25% higher after reporting that it is the first to advance cannabinol into therapeutic clinical trials. Vancouver-based clinical stage biopharmaceutical company InMed Pharmaceuticals Inc. (IN:TSX; IMLFF:OTCQX) , which is engaged in...
Streetwise Reports | January 21, 2020 |

Oil & Gas Midstream MLP Offers 'Multiyear Financial Performance/Flexibility'

A recap of Q4/19 and the outlook for 2020-2021 are provided in a Raymond James report. In a Jan. 31 research note, Raymond James analyst Justin Jenkins reported that for Phillips 66 Partners LP (PSXP:NYSE) , "upside in Q4/19 set the pace for 2020 visibility...
Streetwise Reports | February 7, 2020 |
1 2 3 4 5 6 7 8 9 10 ...